Ultralife Corporation (ULBI) Q1 2023 Results – Earnings Call Transcript

Ultralife Company (NASDAQ:ULBI) Q1 2023 Earnings Convention Name April 27, 2023 8:30 AM ET

Firm Individuals

Jody Burfening – IR

Michael Manna – President and CEO

Philip Fain – CFO

Convention Name Individuals


Good day, and thanks for standing by. Welcome to the Ultralife Company First Quarter 2023 Outcomes Convention Name. At the moment, all individuals are in a listen-only mode. After the audio system’ presentation, there would be the question-and-answer session. [Operator Instructions]. Please be suggested that immediately’s convention is being recorded.

I might now like handy the convention over to your speaker, Jody Burfening. Please go forward, Jody.

Jody Burfening

Thanks, Kathy, and good morning, everybody. And thanks for becoming a member of us this morning for Ultralife Company’s earnings convention name for the primary quarter of fiscal 2023. With us on immediately’s name are: Mike Manna, Ultralife’s President and CEO; and Phil Fain, Ultralife’s Chief Monetary Officer. The earnings press launch was issued earlier this morning and if anybody has not but acquired a duplicate, I invite you to go to the corporate’s web site, www.ultralifecorp.com, the place you may discover the discharge underneath Investor Information within the Investor Relations part.

Earlier than turning the decision over to administration, I want to remind everybody that some statements made throughout this convention name comprise forward-looking statements primarily based on present expectations. Precise outcomes might differ materially from these projected because of varied dangers and uncertainties. The potential dangers and uncertainties that might trigger precise outcomes to vary materially embrace the impression of COVID-19 associated supply-chain disruptions, potential reductions in income from key clients, acceptance of latest merchandise on a world foundation and unsure international financial situations. The corporate cautions buyers to not place undue reliance on forward-looking statements, which mirror the corporate’s evaluation solely as of immediately’s date. The corporate undertakes no obligation to publicly replace forward-looking statements